DK1699437T3 - Fremgangsmåde til fremstilling af faste dosisformer af desmopressin - Google Patents

Fremgangsmåde til fremstilling af faste dosisformer af desmopressin

Info

Publication number
DK1699437T3
DK1699437T3 DK04804367T DK04804367T DK1699437T3 DK 1699437 T3 DK1699437 T3 DK 1699437T3 DK 04804367 T DK04804367 T DK 04804367T DK 04804367 T DK04804367 T DK 04804367T DK 1699437 T3 DK1699437 T3 DK 1699437T3
Authority
DK
Denmark
Prior art keywords
desmopressin
preparation
dosage forms
solid dosage
solid
Prior art date
Application number
DK04804367T
Other languages
Danish (da)
English (en)
Inventor
Kristin Wannerberger
Hans Lindner
Lars-Erik Olsson
Ann-Elisabeth Svensson
Lars Anders Ragnar Nilsson
Pascal Rene Olivier Danglas
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34702338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1699437(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP03029897A external-priority patent/EP1550439B1/en
Priority claimed from US10/746,254 external-priority patent/US7018653B2/en
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK1699437T3 publication Critical patent/DK1699437T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04804367T 2003-12-29 2004-12-28 Fremgangsmåde til fremstilling af faste dosisformer af desmopressin DK1699437T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03029897A EP1550439B1 (en) 2003-12-29 2003-12-29 Method for preparing a solid dosage form of desmopressin
US10/746,254 US7018653B2 (en) 2003-12-29 2003-12-29 Method for preparing solid dosage form of desmopressin
PCT/EP2004/014781 WO2005063202A2 (en) 2003-12-29 2004-12-28 Method for preparing solid dosage form of desmopressin

Publications (1)

Publication Number Publication Date
DK1699437T3 true DK1699437T3 (da) 2007-12-27

Family

ID=34702338

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04804367T DK1699437T3 (da) 2003-12-29 2004-12-28 Fremgangsmåde til fremstilling af faste dosisformer af desmopressin

Country Status (14)

Country Link
EP (1) EP1699437B1 (ja)
JP (1) JP4763617B2 (ja)
KR (1) KR100870679B1 (ja)
AU (1) AU2004308670B2 (ja)
BR (1) BRPI0418240A (ja)
CA (1) CA2490601C (ja)
DE (1) DE602004010302T2 (ja)
DK (1) DK1699437T3 (ja)
ES (1) ES2295962T3 (ja)
MX (1) MXPA06007507A (ja)
NZ (1) NZ546817A (ja)
PL (1) PL209823B1 (ja)
RU (1) RU2334505C2 (ja)
WO (1) WO2005063202A2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018602A1 (en) * 1994-01-11 1995-07-13 Alkermes Controlled Therapeutics, Inc. ORAL DOSAGE FORM OF DESMOPRESSIN (dDAVP)
JP4290792B2 (ja) * 1999-01-11 2009-07-08 カルピス株式会社 造粒物、その製法及びこれを用いた錠剤
CA2362482A1 (en) * 1999-03-03 2000-09-08 Eli Lilly And Company Processes for making pharmaceutical oral ecb formulations and compositions
JP2005506991A (ja) * 2001-10-15 2005-03-10 レーム ゲゼルシャフト ミツト ベシュレンクテル ハフツング ウント コンパニー コマンディートゲゼルシャフト 作用物質としてペプチド又はタンパク質を含有する医薬形を製造するためのコポリマーの使用
BR0309819A (pt) * 2002-05-07 2005-03-01 Ferring Bv Formulações farmacêuticas
DK1473029T3 (da) * 2003-04-30 2005-04-18 Ferring Bv Farmaceutisk præparat som fast dosisform og fremgangsmåde til fremstilling deraf
PT1500390E (pt) * 2003-07-25 2005-10-31 Ferring Bv Composicao farmaceutica como forma de dosagem solida e metodo de producao

Also Published As

Publication number Publication date
EP1699437B1 (en) 2007-11-21
RU2334505C2 (ru) 2008-09-27
WO2005063202A2 (en) 2005-07-14
DE602004010302T2 (de) 2008-10-16
PL381356A1 (pl) 2007-05-28
CA2490601C (en) 2006-05-02
RU2006120954A (ru) 2008-02-10
KR100870679B1 (ko) 2008-11-26
AU2004308670B2 (en) 2007-08-02
AU2004308670A1 (en) 2005-07-14
JP2007517000A (ja) 2007-06-28
CA2490601A1 (en) 2005-06-29
PL209823B1 (pl) 2011-10-31
MXPA06007507A (es) 2007-01-30
NZ546817A (en) 2010-07-30
ES2295962T3 (es) 2008-04-16
DE602004010302D1 (de) 2008-01-03
BRPI0418240A (pt) 2007-04-17
EP1699437A2 (en) 2006-09-13
JP4763617B2 (ja) 2011-08-31
WO2005063202A3 (en) 2006-05-18
KR20060111566A (ko) 2006-10-27

Similar Documents

Publication Publication Date Title
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
DK1611108T3 (da) Fremgangsmåde til fremstilling af telmisartan
DK2308507T3 (da) Fremgangsmåder til behandling af præeklampsi
IS2935B (is) Misnotkunarvarið lyfjaform til skömmtunar um húð
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK2508521T4 (da) Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf
DK1701941T3 (da) Forbindelser til behandling af sygdomme med celleproliferation
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1546122T3 (da) Fremgangsmåde til fremstilling af valsartan
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
DK1407037T3 (da) Fremgangsmåde til fremstilling af tagatose
DK1345939T3 (da) Fremgangsmåde til fremstilling af sulfonamidsubstituerede imidazotriazinoner
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
DK1678135T3 (da) Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser
IS7958A (is) Aðferð til að framleiða metýl 2-dífenýlmetýlsúlfínýlasetat
DK1572613T3 (da) Fremgangsmåde til fremstilling af benzophenoner
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1912961T3 (da) Fremgangsmåde til fremstilling af bepromolin
DK1660485T3 (da) Forbedret fremgangsmåde til fremstilling af alpha-polymorfisk eletriptanhydrobromid
DK1550439T3 (da) Fremgangsmåde til fremstilling af faste dosisformer af desmopressin
DK1727792T3 (da) Fremgangsmåde til fremstilling af semicarbazoner
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1503995T3 (da) Fremgangsmåde til fremstilling af substituerede phenylsulfonylurinstoffer